BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11944335)

  • 1. [Monoclonal antibodies used to differentiate between poliovirus types 1 and 3].
    Shirobokov VP; Kopanitsa LV; Nikolaenko IV; Lipatnikova KI; Sologub VK
    Mikrobiol Z; 2001; 63(6):42-52. PubMed ID: 11944335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A monoclonal antibody panel for the intratypic differentiation of type-2 polioviruses].
    Shyrobokov VP; Nikolaienko IV; Kopanytsia LV; Solohub VK; Ivanova OIe
    Mikrobiol Z; 1997; 59(6):27-36. PubMed ID: 9511373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strain differentiation of polioviruses with monoclonal antibodies.
    Osterhaus AD; van Wezel AL; Stegmann AJ; van Asten JA; Hazendonk AG
    Dev Biol Stand; 1984; 57():135-9. PubMed ID: 6098494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of ELISA for screening McAb against type III polioviruses and its antigenic analysis].
    Gu FZ; Wang SH; Sun YY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Oct; 7(5):359-63. PubMed ID: 2421926
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
    Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
    Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of vaccine-derived type 1 polioviruses displaying similar properties to virulent wild strain Mahoney from sewage in Japan.
    Horie H; Yoshida H; Matsuura K; Miyazawa M; Wakabayashi K; Nomoto A; Hashizume S
    J Med Virol; 2002 Nov; 68(3):445-51. PubMed ID: 12226835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
    Ferguson M; Minor PD; Magrath DI; Schild GC
    Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization epitope patterns of poliovirus strains isolated from cases of acute spinal paralysis and from healthy vaccinated children.
    Persu A; Combiescu M; Murg B; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 1995; 54(1-2):53-63. PubMed ID: 8993114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of allogenic hybridomas for production of monoclonal antibodies against oral polio vaccine strains.
    Gupta CK; Sokhey J; Gupta RK; Singh H
    Vaccine; 1991 Nov; 9(11):853-4. PubMed ID: 1661979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoclonal antibodies against Brunhilde strain of poliovirus type I].
    Tang EH; Jian YQ; Wen YL; Lin JY; Guo R
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Apr; 6(2):150-2. PubMed ID: 6100481
    [No Abstract]   [Full Text] [Related]  

  • 12. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
    Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
    Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparison of the diagnostic value of the virus neutralization reaction and of indirect immunoenzyme analysis using monoclonal antibodies for the intratype differentiation of vaccinal and virulent poliovirus strains].
    Nikolaienko IV
    Lik Sprava; 1998 May; (3):84-6. PubMed ID: 9695574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
    Uhlig H; Rutter G; Dernick R
    Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of hybrid cell lines secreting monoclonal antibodies against poliovirus Type 2.
    Guo R; Tang EH; Jiang YQ; Wen YL; Lu FM; Lin JY
    Chin Med J (Engl); 1983 Sep; 96(9):669-74. PubMed ID: 6317298
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of poliovirus strains isolated in Poland during 1981-1989 using monoclonal antibodies and determination of nucleotide sequence in viral RNA].
    Jarzabek Z
    Med Dosw Mikrobiol; 1991; 43(1-2):63-71. PubMed ID: 1664473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies of four different specificities for neutralization of type 1 polioviruses.
    Humphrey DD; Kew OM; Feorino PM
    Infect Immun; 1982 May; 36(2):841-3. PubMed ID: 6282759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WHO collaborative study on the use of monoclonal antibodies for the intratypic differentiation of poliovirus strains.
    Ferguson M; Magrath DI; Minor PD; Schild GC
    Bull World Health Organ; 1986; 64(2):239-46. PubMed ID: 3017595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The application of immunofluorescence and neutralization McAb tests to typing diagnosis of 286 polio strains].
    Tang E
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Oct; 13(5):367-71. PubMed ID: 1666028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of antigenic profiles of inactivated poliovirus vaccine and vaccine-derived polioviruses by block-ELISA method.
    Rezapkin G; Martin J; Chumakov K
    Biologicals; 2005 Mar; 33(1):29-39. PubMed ID: 15713554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.